News
GlobalData on MSN8d
AGC Biologics and Quell to progress Treg cell therapy developmentThe Milan Cell and Gene Center of Excellence at AGC Biologics will produce LVV material for Treg cell therapy candidates.
Hosted on MSN15d
Viralgen and Trogenix to progress gene therapy for glioblastomaWith the first GMP batch of Trogenix's rAAV vector manufactured at ... set to form a partnership with Axovia Therapeutics to progress the development and manufacturing of an AAV9-based gene ...
Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback